Expectedly, all mice from the control group (GVHD) died within 50 days, while the GVHD mice that received CD1c+ B cells survived well, and the survival rate of mice that received CD1c+ B cells was remarkably higher than those that received CD1c− B cells (Figure 5B). Here, CD1C is linked to graft versus host disease.